Meet the Experts

Beth Schurman is a Partner at Herspiegel and an experienced marketing professional with extensive experience in the pharmaceutical industry. Beth has a broad marketing background, including experience in brand development, new product launches, market shaping, and life cycle management. Her strong leadership, attention to detail, and communication skills have earned her the trust and respect of her clients.

Beth expertly blends marketing strategy, innovative thinking, and rigorous structure to establish market-changing strategies and impactful execution for her clients. Clients value her ability to smoothly transition from strategy development and innovation to project management and analytics. Beth has led a variety of projects spanning therapeutic areas, including oncology, rare disease, diabetes, obesity, infectious disease, CNS and trauma.

Prior to her tenure with Herspiegel, Beth gained extensive marketing experience at both Novo Nordisk and Bristol-Meyers Squibb. She was highly involved in product launch, co-promotions, and in-line brand management in retail and hospital markets.

Beth has an MBA with specializations in Marketing and Management from the Stern School of Business at NYU, and a BA in Biochemistry and Molecular Biology from Rutgers University.

Thought Leadership

Contract Commercial Services
- White Paper: Cell and Gene Therapy Commercialization Innovations
  In this whitepaper, you will discover: The four most common challenges in cell and gene therapy commercialization. Methods to address common product launch challenges. Insights to accelerate and de-risk launch for cell and gene therapy treatments. Read more.
- Article: Roadmap to De-risk Commercialization of a Rare Disease Product
  Explore Herspiegel's expert strategies for successful rare disease launches, from tech innovation to market responsiveness. Learn more now.
- Article: Delivering Cell and Gene Therapies at Scale (VIDEO)
  Discover cell & gene therapy launch secrets with Beth Schurman & Kate Reedy on Herspiegel Conversations. Watch now.
- White Paper: Proven Pharmaceutical Go-To-Market Model
  Learn from our $60B success! Discover Herspiegel's proven 4-step model for pharma go-to-market strategies. Boost your launch now.
- Case Study: First Connected Device Launch Plan
  Explore how Herspiegel's expertise led a groundbreaking connected device launch in healthcare. Dive into our digital and business insights.
- Case Study: First Commercial Launch for Biopharmaceutical Start-Up
  Discover how Herspiegel's guidance powered a biopharma start-up's first Neurology asset launch, crafting their commercial triumph. Learn more.
- White Paper: A New Blueprint for Commercializing Cell and Gene Therapies
  Discover how to successfully commercialize cell & gene therapies. Learn from past challenges – Access our insights for a winning strategy now.
Launch Excellence
- Article: Navigating a Drug Launch: The Launch Plan
  Today there is a laser focus on product performance out of the gate, so there is a lot of pressure to get it right. This means pharma companies need to make sure that they have the right launch team in place before putting together the structure and tactics in their launch plans. Read to learn more.
- Article: Navigating a Drug Launch: How to execute
  How can reps engage physicians beyond office visits in our digital world? Ultimately, this is what the launch teams need to answer when developing the ‘how to execute’ portion of their strategies.
- Article: Navigating a Drug Launch: How to Win
  Pharma companies that have product launches that repeatedly perform beyond expectations know how to develop vision and positioning, create a brand strategy with notable differentiation, and focus on building superior customer experiences. Learn more.
- Article: Navigating a Drug Launch: Where to Play?
  At Herspiegel, we have partnered with biotech and pharma companies big and small and have successfully brought millions of dollars worth of drugs, devices, and treatments to market. But before we get a product out the door, we help launch teams navigate their go-to-market strategies.
- Article: FDA Continued Rejections of Citizen Petitions Highlights Key Lifecycle Challenges for Biologic Manufacturers
  Read about key lifecycle challenges for Biologic Manufacturers in this article.
- White Paper: Cell and Gene Therapy Commercialization Innovations
  In this whitepaper, you will discover: The four most common challenges in cell and gene therapy commercialization. Methods to address common product launch challenges. Insights to accelerate and de-risk launch for cell and gene therapy treatments. Read more.
- Article: Complete Response Letters are Increasing
  Complete Response Letters (CRLs) are increasing. How are pharma companies preparing? Read more.
- Article: Roadmap to De-risk Commercialization of a Rare Disease Product
  Explore Herspiegel's expert strategies for successful rare disease launches, from tech innovation to market responsiveness. Learn more now.
- Article: Navigating a Drug Launch
  Master drug launch success! Herspiegel shares 4-part blog series on de-risking launch plans. Tap into our go-to-market model now.
- Article: Delivering Cell and Gene Therapies at Scale (VIDEO)
  Discover cell & gene therapy launch secrets with Beth Schurman & Kate Reedy on Herspiegel Conversations. Watch now.
- Case Study: Successful Launch of Phase 3 Asset in Different Therapeutic Areas
  Dual-launch success in two areas! Herspiegel expertly guides Phase 3 asset to market. Discover our strategy's impact.
- White Paper: Four Key Elements of Drug Launch Planning
  Master drug launch excellence with our guide on 4 key elements. Download now to define markets, gain insights & strategize your brand.
- Case Study: Early Commercialization for Oncology Start-Up
  Join our journey in guiding an oncology start-up towards successful first product launch with expert strategies. Discover our impact.
- White Paper: Proven Pharmaceutical Go-To-Market Model
  Learn from our $60B success! Discover Herspiegel's proven 4-step model for pharma go-to-market strategies. Boost your launch now.
- White Paper: Complete Response Letter Mitigation
  Facing a CRL can be daunting. Get insights on trends and tactics to mitigate its impact with our expert paper. Use this guide today.
- Case Study: Product Development Process to Optimize Commercial Value
  Maximize your biopharma product's commercial success! Discover how Herspiegel's refined development process can drive market results. Learn more now
- Case Study: First Commercial Launch for Biopharmaceutical Start-Up
  Discover how Herspiegel's guidance powered a biopharma start-up's first Neurology asset launch, crafting their commercial triumph. Learn more.
- White Paper: A New Blueprint for Commercializing Cell and Gene Therapies
  Discover how to successfully commercialize cell & gene therapies. Learn from past challenges – Access our insights for a winning strategy now.
Marketing Excellence
- Article: Navigating a Drug Launch
  Master drug launch success! Herspiegel shares 4-part blog series on de-risking launch plans. Tap into our go-to-market model now.
- Case Study: Successful Launch of Phase 3 Asset in Different Therapeutic Areas
  Dual-launch success in two areas! Herspiegel expertly guides Phase 3 asset to market. Discover our strategy's impact.
- White Paper: Four Key Elements of Drug Launch Planning
  Master drug launch excellence with our guide on 4 key elements. Download now to define markets, gain insights & strategize your brand.
- Case Study: Early Commercialization for Oncology Start-Up
  Join our journey in guiding an oncology start-up towards successful first product launch with expert strategies. Discover our impact.
- Case Study: Product Development Process to Optimize Commercial Value
  Maximize your biopharma product's commercial success! Discover how Herspiegel's refined development process can drive market results. Learn more now